Statistically significant and clinically meaningful improvements in mean ACQ-5 scores were reported at week 16 versus placebo ...

In this excerpt from the new book ‘Speak Data,’ the Wharton professor and best-selling author shares his thoughts on how we interpret and communicate information Data is an omnipresent facet of modern ...

Rezdiffra® treatment significantly improved liver stiffness, fibrosis biomarkers, and markers of clinically significant portal hypertension risk ...

Thousands of climate protesters marched through the Brazilian city of Belem on Saturday in a noisy, diverse and peaceful ...

The infrastructure requirement for America’s AI overhaul is fostering the breaking of bread across partisan lines in the hinterlands.

Mirum Pharma Showcases Leadership in Liver Disease Innovation With Data From LIVMARLI® and Volixibat Clinical Programs at ...

Oral Presentation on Saturday to Highlight Interim Safety and Efficacy Results from the MyPEAK™-1 Phase 1b/2a Clinical Trial in Adults with ...

SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS’’ or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer ...

As artificial intelligence moves deeper into healthcare, executive teams are grappling with how to make it operational, safe, and sustainable. During the AI Summit at Becker’s 13th Annual CEO+CFO ...

Each year, the European Lung Foundation (ELF) recognises outstanding research that advances patient-centred care and promotes ...

Merck’s enlicitide decanoate significantly reduced LDL-C in adults with heterozygous familial hypercholesterolemia in phase 3 CORALreef HeFH trial: Rahway, New Jersey Tuesday, N ...